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Monday, February 22, 2010 355aWe have combined time-resolved fluorescence resonance energy transfer (TR-
FRET) andmolecular dynamics (MD) simulations to elucidate structural changes
in thephosphorylationdomain (PD) of chickengizzard smoothmuscle regulatory
light chain (RLC) bound to smooth muscle myosin. The PD is absent in crystal
structures, leaving uncertainty about themechanism of regulation. Donor-accep-
tor pairs of probes were attached to three site-directed di-Cys mutants, each hav-
ing oneCys at position 129 in theC-terminal lobe and the other at position 2, 3, or
7 in theN-terminal PD. Labeled RLCs, with and without phosphorylation at S19,
were reconstituted intomyosin S1. Time-resolvedFRET identified two structural
states of the RLC, closed and open, which are present in both unphosphorylated
and phosphorylated biochemical states. Phosphorylation shifts the equilibrium
toward the open state by 20-30%. Molecular dynamics simulations, guided by
these and previous spectroscopic studies, confirm the existence of the open and
closed structural states and produce atomic resolution models of these states.
In the closed state, the PD interacts with the surface of the C-terminal lobe. In
the open state, the PD is more helical and straight, resides farther from the C-ter-
minal lobe, and is more mobile. Phosphorylation stabilizes the open state by
forming a specific salt bridge betweenR16 and phosphorylated S19. This confor-
mational shift is consistent with a mechanism of regulation that catalyzes large
structural changes within myosin at a low energetic cost. This work was sup-
ported by grants from NIH (AR32961, AR07612) and the Minnesota Supercom-
puting Institute. We thank Igor Negrashov for excellent technical assistance.
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Stimulated Actin Polymerization Induces Force Potentiation in Swine
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The phenomenon of post-tetanic potentiation, in which a single submaximal
contraction or series of submaximal contractions strengthens a subsequent con-
traction, has been observed in both skeletal and cardiac muscle.
In this study, we describe a similar phenomenon in swine carotid arterial
smooth muscle. We find that a submaximal Kþ depolarization increases the
force generation of a subsequent maximal Kþ depolarization - we term this
‘‘force potentiation.’’
Force potentiation was not associated with a significant increase in crossbridge
phosphorylation or shortening velocity during the maximal Kþ depolarization,
suggesting that the potentiated forcewas not caused by higher crossbridge cycling.
We found that measures of stimulated actin polymerization (higher prior Y118
paxillin phosphorylation, higher prior F actin, and transition to a more solid
rheology evidenced by lower noise temperature and phase angle) present prior
to the maximal Kþ depolarization predicted the degree of force potentiation.
Increased prior contraction alone did not induce force potentiation since read-
dition of Ca2þ to Ca2þ-depleted tissues induced a partial contraction that was
not associated with changes in noise temperature or with subsequent force po-
tentiation.
These data suggest that stimulated actin polymerizationmay produce a substrate
for increased crossbridge mediated force, a process we observe as force poten-
tiation.
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In this report we have investigated a particularly malignant phenotype of Fa-
milial Hypertrophic Cardiomyopathy (FHC) associated with the 166 AsparticAcid to Valine (D166V) mutation in the ventricular myosin regulatory light
chain (RLC). We show that the rates of myosin cross-bridge attachment and
dissociation are significantly different in isometrically contracting cardiac
myofibrils from transgenic (Tg)-D166V compared to Tg-WT mice. A single
molecule approach was taken where the fluorescence anisotropy of rhodamine
phalloidin labeled actin protomers was measured in cardiac myofibrils under-
going isometric contraction. Orientation of an actin molecule oscillated be-
tween two states, corresponding to the actin-bound and actin-free states of
the myosin cross-bridge. The rates of cross-bridge attachment as well as
cross-bridge dissociation were significantly decreased in isometrically con-
tracting Tg-D166V myofibrils (binding, 1.4 s1; detachment, 1.2 s1) com-
pared to Tg-WT myofibrils (binding, 3 s1; detachment, 1.3 s1). The duty ra-
tio of the cross-bridge cycle, equal to the fraction of the total cycle time that
cross-bridge remains attached to actin, was 47% inTg-D166V myofibrils and
30% in Tg-WT. Immunoblotting of cardiac myofibrils used for kinetics studies
demonstrated a large reduction in RLC phosphorylation in Tg-D166V vs. Tg-
WT myofibrils. These data are in accord with our previous findings in skinned
and intact papillary muscles showing slower fiber kinetics and prolonged force
transients in Tg-D166V fibers compared to Tg-WT preparations (Kerrick
et al., FASEB J. 23: 855, 2009). Similarly, the level of RLC phosphorylation
in muscle extracts from Tg-D166V ventricles was decreased. Our cellular and
single molecule data suggest that a mutation-dependent decrease in RLC phos-
phorylationcould initiate the slower kinetics of the D166V cross-bridgesand
ultimately lead to abnormal cardiac muscle contraction. Supported by NIH-
HL071778 (DSC), NIH-AR048622 (JB) and NIH-HL090786 (to JB and DSC).1840-Pos
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To investigate the effects of familial hypertrophic cardiomyopathy (FHC) mu-
tations in the ventricular myosin essential light chain (ELC) we have ex-
changed the human ventricular wild type (WT) and two FHC ELC mutants
(A57G, E143K) for the endogenous porcine ELC in isolated and purified pig
cardiac myosin.To elucidate the importance of the long N-terminus of cardiac
myosin ELC for the actin-myosin interaction, we also exchanged the N-termi-
nal truncation mutant ELC-D43 into native porcine myosin. The phenotype as-
sociated with the A57G mutation consists of a classic asymmetric hypertrophy
with varying pathology and disease progression including sudden cardiac death
(SCD) (Lee, et al. (2001) Am Heart J141, 184-9). The E143K mutation is as-
sociated with a restrictive cardiomyopathy and SCD phenotype (Olson et al.
(2002) Circulation105, 2337-40). We hypothesized that FHC ELC mutants
may bind to the myosin heavy chain with a lower affinity than ELC-WT,
thus affecting the structural integrity of the thick filaments in muscle. SDS-
PAGE demonstrated that indeed the A57G mutation yielded lower percent ex-
change in cardiac porcine myosin compared to WT. We further hypothesized
that as a consequence the interaction of ELC-mutant myosin with actin will
be affected. All ELC-mutant myosins were tested for their ability to bind actin
using fluorescence spectroscopy and pyrene-labeled F-actin.We observed a sig-
nificantly decreased binding affinity for both FHC mutants while the binding of
the ELC-D43 mutant myosin to F-actin was stronger than WT. The latter sup-
ports the hypothesis that the N-terminus of ELC acts as a molecular constrain
inhibiting the actin-myosin interaction. Lower binding affinity of myosin con-
taining the A57G and E143K mutations might be responsible for the develop-
ment of the pathologic cardiac phenotype observed in patients carrying these
FHC mutations. Supported by NIH HL071778 and NIH HL090786.
